Ashley Gallagher

Pharmacists are essential in helping to identify patients at risk for inappropriate prescribing.

The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 lineage did not increase the risk of 29 adverse events of special interest.

Kristen Jones, PharmD, discusses leadership strategies in pharmacy management that prioritize emotional intelligence and communication for enhanced team performance and patient care.

Pharmacy professionals evolve into strategic leaders, mastering emotional intelligence and management skills to navigate complex workplace dynamics and enhance patient care.

Kristen Jones, PharmD, discusses challenging traditional workplace paradigms by emphasizing the human element in pharmaceutical operations.

Kristen Jones, PharmD, discusses pharmacists as leaders at McKesson ideaShare 2025.

The risk of untreated depression for pregnant women can cause adverse outcomes, which can include relapse in mood symptoms, suicide, and overdose death.

Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

From 2008 to 2023, the relative increase of pediatric patients with obesity classes 4 to 5 was 253.1%.

The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients.

New study data reveal the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

Older adults with insomnia face heightened depression risks during inflammation, highlighting the need for targeted monitoring and treatment strategies.

Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.

Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.

Investigators find that the phase 2 trial supports the further development of MK-8527 as an HIV pre-exposure prophylaxis.

New research findings reveal amoxicillin's effectiveness varies in treating invasive pneumococcal disease, highlighting the importance of patient-specific factors in antibiotic therapy.

Older adults are more likely to have chronic diseases, such as lung or heart disease, which makes them more susceptible to invasive pneumococcal disease.

Thomas Sherrer, PharmD, advocates for a team-driven, tech-enhanced approach to pharmacy inventory management, boosting patient care and operational efficiency.

Investigators find that erenumab, a calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, is not a preventive treatment for chronic cluster headache.

Brooklyn Morgan, PharmD, director of state policy at the National Alliance of State Pharmacy Associations, emphasizes the importance of making the pharmacist's voice heard.

Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.

Pharmacists left the conference with fresh ideas, renewed confidence, and a strong sense that they're not in this alone.

The approval is based on the FINEARTS-HF (NCT04435626), showing that the drug achieved a 16% relative risk reduction of cardiovascular death and total heart failure events.

Thomas Sherrer, PharmD, co-owner of Poole's Pharmacy, describes implementing multiple tracking methods to stay ahead of drug shortages.

Thomas Sherrer, PharmD, emphasizes the importance of a team-based approach to inventory control.

Buddy Carter, PBM, US Representative (R-GA), emphasizes the critical role of pharmacists, particularly during the COVID-19 pandemic, and advocates for provider status recognition.

Pharmacists can transform from only being prescription dispensers to health care hubs that offer comprehensive patient care and generate innovative revenue streams.

The key theme, regardless of strategy, is being an engaging member of the community and stepping outside of the counter.

Patients with a single cardiometabolic disease have an approximately 48% greater risk of developing all-cause dementia than those without a cardiometabolic disease.

Efsitora demonstrates noninferior reductions in hemoglobin A1c and similar rates in patients with an A1c level less than 7% compared with common daily insulin.